| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.21 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |